ALUNGcancerdrug available on the NHS halves the risk of death, according to a study. Scientists say exciting study results show osimertinib will increase survival of thousands of British patients. 2 One study found that a lung cancer drug halves the risk of deathCredit: Getty 2 Osimertinib, sold under the name Tagrisso, is already available on the NHS for some patients It works by blocking vital receptors that allow cancer cells to use up energy to grow. The medicine is already being used for some NHS patients after previous research found…
Read MoreTag: lung
AstraZeneca’s new UK lung cancer drug hailed as a ‘game changer’
AstraZeneca’s new UK lung cancer drug is hailed as a ‘game changer’ that can HALF the risk of death By Kate Pickles Updated: 5:43 PM EDT, June 4, 2023 Research has shown that a ‘breakthrough’ British drug can halve the risk of dying from lung cancer. The groundbreaking study found that patients who received osimertinib after surgery were 51 percent more likely to be alive five years later than those given a dummy pill. The daily tablets target non-small cell lung cancer (NSCLC) cancers among people who have a specific…
Read More